InsightRX
↗San Francisco, California, United States
InsightRX is a clinical-stage precision medicine software company that develops model-informed precision dosing (MIPD) platforms for individualized drug dosing. The company's end-to-end solution combines InsightRX Nova (personalized Bayesian dosing for clinical decision support), InsightRX Apollo (advanced PK/PD analytics), and a patented Continuous Learning process that uses real-world patient data to continuously improve dosing model accuracy. InsightRX serves two primary markets: healthcare providers (hospitals and health systems) seeking to reduce medication errors and adverse drug events at the point of care, and pharmaceutical/biotech companies leveraging precision dosing in clinical trial design and drug development. The platform is deployed across 1,000+ hospitals and has personalized more than 4 million dose advices across nearly one million treatment courses.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health / Healthcare Technology
Sub-Industry:Precision Medicine / Clinical Decision Support
SIZE & FINANCIALS
Employees:11-50
Revenue:Not disclosed
Founded:2015
Ownership:private
Status:operating
FUNDING
Stage:Series A
Total Raised:$13.2M
Investors:HealthX Ventures (Series A lead), Rock Health, OSF Healthcare, Leawood Venture Capital, Premier Inc., GreatPoint Ventures, CIBC Innovation Banking (debt 2024)
PIPELINE
Stage:Commercial (software platform)
Lead Drug Stage:Not applicable
Modalities:Software/Digital Health, Bayesian Dosing, PK/PD Analytics, AI/Machine Learning
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:UCSF (University of California San Francisco) - Original collaborators, Stanford Lucille Packard Children's Hospital, Children's Hospital Los Angeles, Sentara Healthcare, OSF Healthcare, OSF Innovation, Healix (outpatient infusion therapy partnership), Máxima Medical Center (Netherlands)
COMPETITION
Position:Leader
Competitors:DoseMeRx (acquired by Fairlong Capital, Jan 2023), ExactCure (merged with Quantum Genomics, April 2024), Rx Studio, PrecisePK
LEADERSHIP
Key Executives:
Sirj Goswami - CEO & Co-Founder
Ron Keizer - Chief Scientific Officer & Co-Founder
Ranvir Mangat - Chief Operating Officer, Pharmacometric Applications & Co-Founder
Scientific Founders:Sirj Goswami, PhD, Ron Keizer, PhD, PharmD, Ranvir Mangat, M.Eng
Board Members:Seth Teicher
LINKS
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of InsightRX and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with InsightRX. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.